19 results
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
20 May 20
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
4:04pm
it is aware that, if publicly disclosed hereafter, would adversely reflect on the business, reputation or goodwill of the Company.
(b) Advisor
8-K
EX-99.1
idcrm
13 Aug 18
Departure of Directors or Certain Officers
12:00am
10-K
qvn92
31 Mar 15
Annual report
12:00am
424B4
vmta0a
13 Feb 15
Prospectus supplement with pricing info
12:00am
S-1
qz0 ntg1tmcfo
13 Jan 15
IPO registration
12:00am
S-1
EX-10.23
weoaju4iul76j0ryuvd7
13 Jan 15
IPO registration
12:00am
DRS/A
64eusi377au5
21 Nov 14
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next